Company Active LTD

Company profile

Sagentia Limited

UK company 02081960, incorporated on 9 December 1986.

Technology Innovation Consultants | Sagentia Innovation

Sagentia Innovation brings together advisory skills and product development capabilities to offer clients a fully integrated range of R&D consultancy services

Company number
02081960
Incorporated
9 Dec 1986
Companies House status
Active

Company identity

Founded / incorporated
9 December 1986

Company number 02081960

Verify at Companies House
Legal name
SAGENTIA LIMITED
Company type
Private Limited Company
Region
East of England
Registered address
HARSTON MILL ROYSTON ROAD
HARSTON
CAMBRIDGE
CB22 7GG
Insolvency history
No

Corporate ownership

Updated 07 Jul 2026 09:49

1 level 1 ultimate controller Controls 1
1
Company Active LTD
Sagentia Limited
CRN 02081960
2
Direct and ultimate controller Active PLC
Science Group PLC
CRN 06536543

Company events

Reference milestones and recent Companies House filing stream events.

6 events
25 Jul
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

30 Sep
2026

Accounts due

Accounts Due

Next accounts due date

15 Jul
2026

Confirmation Statement With No Updates

Confirmation-statement

CS01 | Transaction MzUzMjkyODk5OGFkaXF6a2N4

Published 15 Jul 2026 13:15

11 Jul
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec
2024

Accounts filed

Accounts

Last accounts made up date

09 Dec
1986

Incorporated

Inception

Company registered at Companies House

Public funding

3 awards
First funded
2009
Funded years
2009, 2010, 2013
Age at first award
22 years

Projects

2013 Feasibility Studies

Feasibility of a molecular imaging camera for surgical specimen analysis

1 Oct 2013 to 31 Mar 2014

Awarded
£33,494
Total cost £44,659

Nearly 1 in 4 breast cancer patients in the UK will require re-operation after surgery. The consequences, in addition to repeat operations, include delayed adjuvant treatment, increased likelihood of distant recurrence, poorer cosmetic outcomes, emotional distress, and enormous financial cost to the NHS. Breast cancer requires re-operation so frequently a...

2010 Collaborative R&D

Polymer Photovoltaic Architectural Glass

1 Apr 2010 to 31 Mar 2012

Awarded
£97,700
Total cost £172,593

Project PPAG (Photovolatic Architectural Glass) aims to develop a working prototype/demonstrator of a scaled up OPV glazing module, which meets defined market application performance & specification requirements. The project aims to deliver a proof of technical feasibility both at laboratory scale & for large area module application, & evaluate electrical...

2009 Collaborative R&D

Advance Secondary Pharmaceutical Manufacturing

1 Oct 2009 to 31 Mar 2012

Awarded
£33,882
Total cost £67,764

In order to underpin the competitiveness of the UK pharmaceutical industry, a step change improvement in manufacturing efficiency is needed. This project aims to deliver this for production of the largest proportion of dosage forms (tablets). The efficiency gains are targeted at improved manufacturing precision, improved productivity and improved mass yie...

Product types

Collaborative R&D Feasibility Studies